New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients.

Scantlebury, Ron Shapiro, John J. Fung, Andreas G. Tzakis, J McCauley, Christopher Jensen, R. L. Simmons, TE Starzl

PubMed · 1991 · 73 citations · 3 references

Full text

Open access

Concepts

Abstract

The development of diabetes mellitus in the renal transplant population was first reported by Starzl in 1964 and was attributed to the use of steroids.1 Since then, posttransplant diabetes mellitus has been associated with the use of other immunosuppressive agents, such as cyclosporine (CyA). Because FK 506 is also thought to be diabetogenic,2 We retrospectively looked at the incidence of new onset diabetes mellitus in patients treated primarily with either FK 506 or CyA in a randomized trial of kidney transplantations done at the University of Pittsburgh from February 1990 to May 1991.

References

3